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ABSTRACT
Gene targeting by single-stranded oligodeoxyribo-
nucleotides (ssODNs) is a promising tool for
site-specific gene modification in mouse embryonic
stem cells (ESCs). We have developed an ESC line
carrying a mutant EGFP reporter gene to monitor
gene correction events shortly after exposure to
ssODNs. We used this system to compare the
appearance and fate of cells corrected by sense or
anti-sense ssODNs. The slower appearance of
green fluorescent cells with sense ssODNs as
compared to anti-sense ssODNs is consistent with
physical incorporation of the ssODN into the
genome. Thus, the supremacy of anti-sense
ssODNs, previously reported by others, may be
an artefact of early readout of the EGFP reporter.
Importantly, gene correction by unmodified
ssODNs only mildly affected the viability of tar-
geted cells and did not induce genomic DNA
double-stranded breaks (DSBs). In contrast,
ssODNs that were end-protected by phospho-
rothioate (PTO) linkages caused increased H2AX
phosphorylation and impaired cell cycle progression
in both corrected and non-corrected cells due to
induction of genomic DSBs. Our results demon-
strate that the use of unmodified rather than PTO
end-protected ssODNs allows stable gene modifi-
cation without compromising the genomic integrity
of the cell, which is crucial for application of
ssODN-mediated gene targeting in (embryonic)
stem cells.
INTRODUCTION
Gene targeting by single-stranded oligodeoxyribonu-
cleotides (ssODNs) is a promising tool for introducing
site-speciﬁc sequence alterations into the genome of
mammalian cells. The procedure only requires short syn-
thetic ssODNs that are homologous to the target locus,
except for a single or a few centrally located bases that
comprise the desired genetic alteration. Although the
exact mechanism underlying ssODN-mediated gene tar-
geting remains elusive, several reports have demonstrated
the involvement of DNA replication. Synchronizing cells
in the S phase of the cell cycle or reducing the rate of
replication fork progression improved the targeting fre-
quency in various cell types (1–4). It has therefore been
postulated that the ssODN anneals to its complementary
genomic target sequence within the context of a replica-
tion fork. Extension of the ssODN by the replication ma-
chinery would result in incorporation of the ssODN into
the newly synthesized DNA strand (5,6). Following an-
nealing, DNA mismatches are formed between the
ssODN and its chromosomal complement. We have pre-
viously shown that these mismatches are recognized and
removed by the DNA mismatch repair (MMR) system,
thereby preventing introduction of the desired genetic al-
teration. Deletion or down-regulation of the central
MMR gene Msh2 dramatically improved the targeting fre-
quency in mouse embryonic stem cells (ESCs) (7,8).
Recently, this inhibitory effect of the MMR system has
been conﬁrmed in human hepatocytes (9), CHO-K1 cells
(10) and HEK293T La cells (11). The involvement of the
MMR system, which functions to correct replication
errors that escape proofreading, provides an additional
indication for ssODN-mediated gene targeting to take
place during replication.
Many reports have demonstrated the feasibility of
ssODN-mediated gene targeting using mutant EGFP
reporter systems in a variety of cell lines (2,10–14).
From experiments using EGFP reporters some general
conclusions have been drawn: (i) anti-sense ssODNs com-
plementary to the non-transcribed strand were most ef-
fective (1,3,12,13); (ii) protection of ssODNs against
nucleolytic degradation by phosphorothioate (PTO)
linkages (10,12) or locked nucleic acid (LNA) bases (15)
enhanced the targeting frequency; (iii) correction by
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response, including activation of the ATM/ATR
pathway and phosphorylation of histone H2AX, due to
the formation of genomic double-stranded DNA breaks
(DSBs) (11,13,14). As a result, most of the corrected cells
arrested in the S (14) or G2 phase (2,10,11) of the cell cycle
and were rapidly diluted by the proliferating uncorrected
cells in the population. Remarkably, these conclusions did
not match the results we have obtained previously using a
mutant neo reporter ESC line, in which the formation of
G418-resistant colonies served as readout for the targeting
frequency: in our neo ESC line, sense ssODNs performed
better than anti-sense ssODNs and PTO modiﬁcations
decreased the targeting frequency (7,16). It is unclear
whether these discrepancies are due to the use of different
reporter systems and different cell types. In particular, it is
important to assess whether ESCs modiﬁed by ssODN-
mediated gene targeting suffer from DNA damage as
such cells need to retain pluripotency and germ line com-
petence to allow the generation of mutant mice (8,17).
In the present study, we have generated a novel Msh2-
deﬁcient mouse ESC line that carries a single copy of a
mutant EGFP reporter gene at the same chromosomal
position as the previously described mutant neo reporter
gene (7,8,16). This EGFP reporter cell line enabled us to
monitor gene correction events already 24h after ssODN
exposure and to study the fate of corrected cells upon
further culturing. Speciﬁcally, we have compared the
fate of cells corrected by either sense or anti-sense
ssODNs. This experiment provided strong support for a
model in which sequence alteration occurs through in-
corporation of the ssODN into the genome during DNA
replication. Importantly, gene targeting by unmodiﬁed
ssODNs only mildly affected the viability of the targeted
cells, which may facilitate future therapeutic applications.
MATERIALS AND METHODS
Cell culture conditions
129/Ola-derived E14-IB10 ESCs were cultured on MEF
feeders in Glasgow minimal essential medium supple-
mented with 10% foetal calf serum (FCS), 1mM sodium
pyruvate, 1  non-essential amino acids, 1mM
2-mercaptoethanol and 1000U per milliliter of leukemia
inhibitory factor. For transfections and antibiotic selec-
tions, ESCs were cultured onto gelatin-coated plates in
BRL (buffalo–rat liver cells)-conditioned medium.
Neo reporter cell line
We developed a selectable mutant neomycin (neo) reporter
cell line in which the start codon of the neo resistance gene
was mutated from ATG to AAG (Figure 1). A single copy
of the mutant neo reporter gene was stably integrated into
the Rosa26 locus of Msh2-deﬁcient ESCs as described
earlier (7).
EGFP reporter cell lines
Plasmid pEGFP-N1 carries the enhanced green ﬂuores-
cent protein (EGFP) ORF under the control of the
CMV IE promoter/enhancer (Clontech). The coding
sequence of EGFP without start codon was ampliﬁed by
PCR from pEGFP-N1 using primers 50-CGAGGTACCA
TGTGAGCAAGGGCGAGGA-30 and 50-CTAGAGTC
GCGGCCGCTTTAC-30 to introduce KpnI and NotI
sites (underlined). To generate a mutant EGFP start
region, we annealed two synthetic DNA oligonucleotides
encoding the start region of the mutant neo reporter in
order to obtain a double-stranded DNA fragment with
BglII and KpnI overhangs (50-GATCTGACCCAATTC
TAGAGCCGCCACCAAGGCCTATGCATCGAGCTT
GGATGGATTGCACGCAGGGTAC-30). The mutant
EGFP start region was ligated together with the KpnI/
NotI-digested EGFP PCR product (without start region)
into the BglII and NotI sites of pEGFP-N1. Similarly,
a plasmid with a wild-type (WT) start region (ATG
instead of AAG) was constructed for control purposes.
Subsequently, the 1.7-kb pCMV-EGFP-SV40pA
fragment was ampliﬁed using the Expand Long
Template PCR system (Roche) and primers 50-CCGCTC
GAGATTAATAGTAATCAATTACGGGGT-30 and
50-CCGCTCGAGCTTAAGATACATTGATGAGTTTG
G-30 and inserted into the XhoI site of the Rosa26-His
targeting vector.
A single copy of the mutant and WT EGFP gene was
stably integrated into the Rosa26 locus of Msh2-deﬁcient
ESCs as described earlier (7). Single copy integration was
conﬁrmed by Southern blot analysis.
Transfection
ssODNs were transfected following the TransFast-
mediated transfection method described earlier (8).
Brieﬂy, 7 10
5 ESCs were seeded onto a gelatin-coated
6-well in BRL-conditioned medium the day before trans-
fection. For one well, 3mg of ssODNs and 27mlo f
TransFast transfection agent (Promega) were diluted in
1.4ml FCS-free medium and incubated for 15min at
room temperature. After 75min of exposure to the trans-
fection mixture at 37 C, 4ml of BRL-conditioned medium
with FCS was added to the cells. Cells were harvested for
ﬂow cytometry at the indicated time points after transfec-
tion. The targeting frequency is the number of
EGFP-positive cells per 10
5 cells that were analysed by
ﬂow cytometry.
Cells were exposed to 50mM hydroxyurea (Sigma-
Aldrich) for 6h prior to ssODN transfection and for
another 22h during ssODN exposure.
Oligonucleotides
ssODNs were designed to correct the mutant start region
of the neo or the EGFP reporter gene by introducing an
in-frame ATG start codon (sequences of sense ssODNs
are listed in Figure 1). Anti-sense ssODNs introduce iden-
tical base changes but have opposite polarity (i.e. are com-
plementary to the non-transcribed strand). When
indicated, ssODNs were modiﬁed with either three PTO
linkages or a single LNA base on each end to protect them
against nucleolytic degradation. ssODNs were purchased
from Sigma-Aldrich and Eurogentec.
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EGFP region
Msh2
 /  mEGFP ESCs were exposed to unmodiﬁed
anti-sense ssODN 1m for 24h after which the
EGFP-positive cells were separated by ﬂow cytometry.
After genomic DNA isolation, the EGFP region was
ampliﬁed by PCR and the resulting products were
cloned into pGEM-T Easy (Promega). DNA from 115
clones was digested with the diagnostic restriction
enzyme NcoI. Sequence analysis of the EGFP region con-
ﬁrmed the presence of the ssODN-directed nucleotide
alteration.
Flow cytometry
Quantiﬁcation of EGFP-positive cells was performed on a
CyAn ADP ﬂow cytometer using Summit V4.3.01
software for analysis (DAKO Cytomation). Cells were
harvested 24h after transfection and resuspended in
PBS supplemented with 0.1% FCS and DAPI
(40,60-diamidino-2-phenylindole) in order to exclude dead
cells from the analysis. Cells were gated based on cell size
(FSC/SSC), doublet discrimination (pulse width/SSC) and
viability (DAPI/SSC). For each sample  4 10
6 cells
were acquired and analysed.
Cell sorting
Cell sorting was conducted on a BD FACSAria ﬂow
cytometer (BD Biosciences). Cells were harvested 24h
after ssODN transfection and resuspended in PBS supple-
mented with 2% FCS. Cells were separated by a FSC/SSC
amplitude gate; doublets were excluded by FSC/SSC
width gates.
Figure 1. Correction of a mutant EGFP reporter gene by ssODNs. (A) Sequence of the mutant neomycin (neo) and EGFP reporter genes in which
the start codon (ATG) is replaced for AAG (Asterisk). Activity of the reporter genes can be restored by ssODNs that substitute one (1m) or 4nt
(4N) (indicated in red) to create a new ATG start codon (underlined). Sequences of sense ssODNs complementary to the transcribed strand are
shown. Arrow indicates the direction of the Rosa26 promoter. NcoI indicates the restriction site that is generated by correction with ssODN 1m.
(B) Representative ﬂow cytometry dot plots of Msh2
 /  mEGFP cells either untransfected (left panel) or transfected with ssODN 1m sense
(middle panel) or 1m anti-sense (right panel) analysed 24h after ssODN transfection. (C) Sequence analysis of genomic DNA showing precise
correction by ssODN 1m.
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Msh2
 /  mEGFP ESCs were exposed to various types of
anti-sense ssODN 1m for 24h and separated into 2000
EGFP-positive and -negative cells. For control purposes,
Msh2
 /  WT EGFP ESCs were mixed with EGFP-
negative Msh2
 /  mEGFP ESCs and subsequently
sorted. The sorted cells were plated onto three
gelatin-coated 100mm dishes. After 8–10 days, surviving
colonies were stained with Leishman’s eosin methylene
blue solution (Merck) and counted. The colony survival
of EGFP-positive cells was normalized to the colony
survival of EGFP-negative cells that had been exposed
to the same ssODNs.
For the Cy5-ssODN uptake experiments, Msh2
 /  neo
ESCs were transfected with 50-Cy5-labelled sense ssODN
4N mixed with unlabelled sense ssODN 4N (ratio 1:4).
The day after transfection, cells were binned into four
separate groups based on their Cy5 ﬂuorescence signal
[mean Cy5 ﬂuorescence (a.u.) in bin 1,1  10
3; bin 2,
4.6 10
3; bin 3, 1.2 10
4; bin 4, 3.5 10
4].
Approximately 2.0–2.5 10
6 cells were sorted per bin in
two replicate runs per experiment. For each bin, cells were
plated onto two gelatin-coated 100mm dishes at 1000
cells/dish to assess their colony-forming ability. The re-
mainder of the cells was plated for G418 selection onto
three gelatin-coated 100mm dishes to determine the tar-
geting frequency. G418 selection (800mg/ml; GIBCO-
Invitrogen) was started 24h after sorting. After 8–10
days, surviving colonies were stained and counted.
Targeting frequencies were calculated by dividing the
number of G418-resistant colonies by the number of
cells that were plated after sorting.
MPM2 staining
After exposure to anti-sense ssODN 1m for 24h, Msh2
 / 
mEGFP ESCs were treated with nocodazole (250ng/ml)
for 12h and harvested. Cells were ﬁxed in 1%
paraformaldehyde for 15min on ice, washed and
permeabilized in 90% ice-cold methanol and stored at
 20 C for at least 2h. Cells were washed three times
with 1% BSA in PBS and incubated with anti-MPM2
antibody (1:100; Upstate Biotechnology) in 5% BSA,
0.2% Triton X-100 in PBS overnight at 4 C. After two
washing steps in 1% BSA/PBS, cells were subsequently
stained with Cy5-conjugated anti-mouse antibody and
counterstained with DAPI. EGFP and Cy5 ﬂuorescence
were simultaneously quantiﬁed on a CyAn ADP ﬂow
cytometer. For each sample, 1–3 10
6 cells were acquired.
Analysis of H2AX phosphorylation
Msh2
 /  mEGFP ESCs were exposed to anti-sense
ssODN 1m for 24h and ﬁxed and permeabilized as
described earlier. Cells were incubated with Alexa Fluor
647-conjugated g-H2AX (Ser 139) antibody (1:50; Cell
Signaling Technology Inc.) in 5% BSA, 0.2% Triton
X-100 in PBS overnight at 4 C. After two washing steps
in 1% BSA/PBS, cells were counterstained with DAPI.
EGFP and Alexa Fluor 647 ﬂuorescence were simultan-
eously quantiﬁed on a CyAn ADP ﬂow cytometer.
Mock-transfected Msh2
 /  mEGFP cells (without
ssODN), Msh2
 /  WT EGFP cells and Msh2
 / 
mEGFP cells exposed to 10mM etoposide for 4h were
included as controls. For each sample, at least 2 10
4 of
the control cells and 1–2 10
6 of the ssODN-transfected
cells were acquired.
Neutral comet assay
Msh2
 /  mEGFP ESCs were exposed to unmodiﬁed or
PTO-modiﬁed anti-sense ssODN 1m for 24h and
separated into EGFP-positive and EGFP-negative cells
by ﬂow cytometry. Mock-transfected Msh2
 /  mEGFP
cells (without ssODN), Msh2
 /  WT EGFP cells, and
Msh2
 /  mEGFP cells exposed to 25Gy of g-irradiation
were included as controls. The neutral comet assay was
performed as previously described (18). Brieﬂy,  8000
sorted cells from each population were resuspended in
1.2ml 0.75% low-gelling-temperature agarose
(Sigma-Aldrich) at 40 C and pipetted onto glass slides
pre-coated with agarose. After gelling for 2min, slides
were immersed into N1 lysis buffer (2% sarkosyl, 0.5M
Na2EDTA, 0.5mg/ml proteinase K) and incubated at
37 C in the dark for 22h. After lysis, slides were rinsed
three times in N2 solution (90mM Tris, 90mM boric acid,
2mMNa 2EDTA pH8.5) for 30min at RT. Then, electro-
phoresis was conducted in fresh N2 solution for 25min at
0.6V/cm. Slides were stained in 2.5mg/ml propidium
iodide for 20min. Images were captured using a Zeiss
AxioObserver Z1 inverted ﬂuorescence microscope
equipped with a Hamamatsu ORCA-ER B/W CCD
camera using identical exposure settings. Images were pro-
cessed using AxioVision software (Zeiss). The comets tail
moment (TM) was determined using the CASP software,
version 1.2.2 (www.casp.of.pl). For each sample, the TM
of at least 80 randomly chosen cells was measured.
RESULTS
Reporter cell lines
To monitor the frequency of ssODN-mediated gene tar-
geting, we used our previously described neomycin (neo)
reporter system in which the neo gene was mutated by a
single base substitution in the start codon (ATG to AAG;
Figure 1A). In addition, we constructed a mutant EGFP
(mEGFP) reporter gene of which the translational start
site was replaced by the mutant neo start sequence
(Figure 1A). Single copies of the mutant neo and the
mEGFP genes were stably integrated into the Rosa26
locus of Msh2-deﬁcient mouse ESCs (7). ssODNs of
35–37nt containing one (1m) or four (4N) centrally-
located nucleotide substitutions were used to correct the
mutant start sequence or to generate a novel ATG start
codon, respectively. Gene correction by ssODN 1m also
generates a diagnostic NcoI restriction site (Figure 1A).
Correction of the neo reporter gene was monitored by the
appearance of G418-resistant colonies after 8–10 days,
while correction of the mEGFP reporter resulting in
EGFP ﬂuorescence could already be detected 24h after
ssODN transfection using ﬂow cytometry (Figure 1B).
NcoI restriction analysis of ampliﬁed genomic DNA
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anti-sense ssODN 1m conﬁrmed that EGFP sequence cor-
rection had taken place at the chromosomal level (not
shown). The accuracy of the sequence alteration was con-
ﬁrmed by sequence analysis (Figure 1C). These reporter
systems allowed us to compare the frequency of
ssODN-mediated gene targeting in mouse ESCs immedi-
ately and several days after exposure to ssODNs,
providing information about the stability of the
introduced sequence alteration, possible toxicity of the
ssODNs and the viability of corrected cells.
Recovery of gene correction events varies with the
time of readout
We used the mEGFP reporter gene to accurately compare
the targeting efﬁcacy of unmodiﬁed and chemically-
modiﬁed ssODN 1m (Figure 2A) and ssODN 4N
(Figure 2B). ssODNs were either in the sense or the
anti-sense orientation with respect to transcription of the
mEGFP gene. As previously shown for other mutant
EGFP reporter cell lines (1,3,12,13), we found that
anti-sense ssODNs appeared to be 5- to 20-fold more ef-
fective than sense ssODNs, when the number of
EGFP-positive cells was determined 24h after ssODN
exposure (Figure 2A and B, black bars). Addition of
three ﬂanking PTO linkages or a single LNA base at
each end to protect the ssODN against nucleolytic degrad-
ation improved the frequency, in particular of anti-sense
ssODNs. Remarkably however, when EGFP expression
was analysed 8 days after ssODN exposure, the targeting
frequency of anti-sense ssODNs had dramatically
decreased, whereas the targeting frequency of sense
ssODNs had increased (Figure 2A and B, grey bars).
The strand bias was now in favour of the sense ssODNs,
which is in agreement with our previous results using the
neo reporter system (16). Particularly, PTO-modiﬁed
anti-sense ssODNs, although being the most effective at
24h after ssODN exposure, showed the strongest reduc-
tion in the number of EGFP-positive cells after 8 days
(39- versus 6-fold reduction for unmodiﬁed anti-sense
ssODN 1m, Figure 2A).
Physical incorporation of ssODNs during DNA replication
Different models have been proposed for the mechanism
of ssODN-mediated gene targeting [reviewed in ref. (19)].
In one model (Figure 8A, model I), the ssODN anneals to
its chromosomal complement and serves as a template for
repair of this chromosomal DNA strand. If this were the
case, anti-sense ssODNs would stimulate substitution of
nucleotides at the non-transcribed strand, whereas sense
ssODNs would lead to alteration of the transcribed
strand. Support for such a model was obtained in
murine myoblasts (20). In an alternative model
(Figure 8A, model II), the ssODN becomes physically
integrated into the genome within the context of either a
D-loop or a replication fork. In this case, the reverse
would take place: anti-sense ssODNs would lead to
sequence alteration of the transcribed strand and sense
ssODNs to alteration of the non-transcribed strand.
Correction of the transcribed strand will lead to
immediate EGFP expression, whereas correction of the
non-transcribed strand will require an extra round of
DNA replication to copy the base alteration(s) to the
transcribed strand before EGFP expression can be
detected.
To discriminate between these two models, we
quantiﬁed the number of EGFP-positive cells either
obtained with sense or with anti-sense ssODNs every
24h over a period of 8 days. As shown in Figure 3A
(black bars), the targeting frequency of sense ssODN 1m
was only 3.0±1.6 10
 5 at the 24h time point (Day 1),
but sharply increased to a maximum of 14.5±1.9 10
 5
on Day 2. During the next two days, the number of
EGFP-positive cells slightly decreased and stabilized at a
frequency of 11.0±1.5 10
 5 on Day 4. Anti-sense
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Figure 2. Gene correction frequencies by different types of ssODNs in
Msh2-deﬁcient mEGFP ESCs. (A) Unmodiﬁed (unm), PTO- and
LNA-modiﬁed sense and anti-sense ssODN 1m were used to correct
the mEGFP gene in Msh2-deﬁcient ESCs. The number of
EGFP-positive cells was determined 24h (black bars) and 8 days
(grey bars) after ssODN transfection. (B) Correction of the mEGFP
gene by unmodiﬁed (unm), PTO- and LNA-modiﬁed sense and
anti-sense ssODN 4N. Error bars represent the standard deviation
(SD) of three independent experiments.
6960 Nucleic Acids Research, 2010,Vol.38, No. 20ssODN 1m showed the maximum targeting frequency
(35.0±6.2 10
 5) already on Day 1 (Figure 3B, black
bars), after which the number of EGFP-positive cells grad-
ually decreased until Day 4–5 and stabilized at a frequency
of 4.5±0.4 10
 5. These observations indicate that the
genetic modiﬁcation induced by sense ssODNs required
an extra round of DNA replication to become expressed,
supporting the model that the sense ssODNs became phys-
ically integrated into the non-transcribed strand. The im-
mediate EGFP-positivity observed with the anti-sense
ssODNs indicates that these ssODNs had integrated into
the transcribed strand.
This model provides a simple explanation for the
decline of EGFP-positive cells obtained following
exposure to anti-sense ssODNs (Figure 3B). Incorporation
of anti-sense ssODNs into the transcribed strand immedi-
ately provides a template for EGFP production, probably
already in the G2 phase of the cell cycle (Figure 8C).
However, in these cells only one of the four single DNA
strands contains the corrected start codon. To conﬁrm
this, we ampliﬁed the genomic EGFP region from
EGFP-positive cells that were sorted 24h after exposure
to anti-sense ssODN 1m. Individual fragments were
cloned and analysed for the presence of the diagnostic
NcoI site, indicative of the ssODN-mediated sequence cor-
rection. Indeed, 24 out of 115 analysed clones (21%) con-
tained the NcoI site, which is in fair agreement with
modiﬁcation of only one of the four DNA strands
(Figure 8C, day 1). Subsequent semi-conservative DNA
replication and cell division will gradually dilute the
number of EGFP-positive cells, theoretically 4-fold. In
contrast, cells corrected by sense ssODNs, need to repli-
cate their DNA once to transmit the genetic modiﬁcation
to the transcribed strand (Figure 8B), which is reﬂected by
the sharp increase in EGFP-positive cells on Day 2
(Figure 3A). The modest decline of EGFP-positive cells,
which we reproducibly observed at Day 4, indeed indicates
that EGFP was expressed in G2 cells immediately after the
corrected start codon was transmitted to the transcribed
strand. Because EGFP has a half-life of  24h (21), the
ﬂuorescent signal may be transmitted to both daughter
cells and slowly fade in one cell, while the other carries
the corrected DNA template and will stably express EGFP
ﬂuorescence (Figure 8B and C).
These observations conﬁrm our previous hypothesis
that ssODN-mediated gene targeting in mouse ESCs
occurs within the context of a replication fork.
Incorporation of the sense ssODN into the lagging
strand, which is more accessible during DNA replication
than the leading strand, could explain the observed su-
premacy of sense over anti-sense after 8 days (Figure 3).
We have previously shown that hydroxyurea treatment
resulted in enhanced targeting frequencies in Msh2
 / 
neo ESCs (16). Hydroxyurea causes depletion of intracel-
lular dNTPs, which reduces the rate of DNA synthesis
(22). Slowing down replication fork progression may
increase the exposure of the single-stranded DNA
regions that are present during replication, particularly
in the lagging strand. Here, we investigated the effect of
hydroxyurea on the frequency of sense and anti-sense
ssODN-mediated correction of the mEGFP reporter over
a time course of 8 days. Msh2
 /  mEGFP ESCs were
incubated with 50mM hydroxyurea between 6h before
and 22h after ssODN exposure. For sense ssODN 1m,
hydroxyurea treatment resulted in a 1.5-fold increase in
targeting frequency (Figure 3A, grey bars), conﬁrming our
results obtained with the neo reporter (16). However, the
targeting frequencies of anti-sense ssODN 1m were
not signiﬁcantly altered upon hydroxyurea treatment
(Figure 3B, grey bars). The observation that hydroxyurea
augmented the accessibility of the target locus to sense
ssODNs, strongly suggests that these ssODNs were
incorporated into the lagging strand.
Unmodiﬁed ssODNs only mildly reduced the survival of
corrected cells
The gradual loss of EGFP-positive cells upon gene correc-
tion by anti-sense ssODNs as shown in Figure 3B, has also
been observed by others (2,11,14). In these experiments,
cells corrected by PTO-modiﬁed ssODNs showed a
reduced viability due to high levels of DNA damage.
We therefore investigated whether ssODN-mediated gene
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Figure 3. Time course of recovery of EGFP-positive cells obtained by
unmodiﬁed ssODN 1m. Msh2
 /  mEGFP ESCs were exposed to
ssODN 1m without treatment (black bars), or in the presence of
50mM hydroxyurea (HU; grey bars). The number of EGFP-positive
cells was quantiﬁed by ﬂow cytometry at the indicated time points
after transfection. Error bars represent the SD of four independent
experiments. (A) Correction by unmodiﬁed sense ssODN 1m (1m).
(B) Correction by unmodiﬁed anti-sense ssODN 1m (1mas).
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hours after exposure of Msh2
 /  mEGFP ESCs to various
types of anti-sense ssODN 1m, EGFP-positive and
-negative cells were separated by ﬂow cytometry and
plated to determine their colony-forming ability. For all
types of ssODNs, the viability of EGFP-positive cells was
reduced compared to EGFP-negative cells (Figure 4).
However, Msh2
 /  ESCs expressing a WT EGFP gene
showed 75% survival compared to EGFP-negative
Msh2
 /  mEGFP reporter cells, indicating that EGFP ex-
pression itself already reduced cell viability. Corrected for
EGFP toxicity, we found that 73% of EGFP-positive cells
obtained with unmodiﬁed or LNA-modiﬁed ssODNs were
able to form colonies. In contrast, only 27% of the
EGFP-positive cells obtained with PTO-modiﬁed
ssODNs survived. Thus, the apparent loss of cells cor-
rected by unmodiﬁed anti-sense ssODNs observed in
Figure 3B can largely be explained by dilution of the cor-
rected DNA strand due to semi-conservative DNA repli-
cation and to a minor extent by reduced viability of the
targeted cells. In contrast, the loss of cells corrected by
PTO-modiﬁed ssODNs is aggravated by a strong reduc-
tion in cell viability.
ssODN uptake did not affect survival
The reduced viability of corrected cells may be due to
toxicity of high levels of ssODNs in cells. To investigate
whether unmodiﬁed ssODNs conferred toxicity, we
determined the cell viability as a function of the level of
ssODN uptake. Msh2
 /  neo cells were exposed to
50-Cy5-labelled sense ssODN 4N and sorted into four
equal bins based on their Cy5 ﬂuorescence signal 24h
after transfection. After sorting, part of the cells was
plated to assess their colony-forming ability, while the re-
mainder of the cells was subjected to G418 selection to
determine the targeting frequency. Although the sorting
procedure reduced the colony-forming ability of ESCs,
there was no correlation between cell viability and the
level of Cy5-ssODN uptake (Figure 5A). Thus, cells with
a high Cy5-ssODN uptake (bin 4) were as viable as cells
with a low uptake (bin 1), indicating that the presence of
unmodiﬁed ssODNs in cells did not affect cell viability.
On the other hand, increased Cy5-ssODN uptake did
result in an increased targeting frequency, as reported pre-
viously (23). Cells with a 10- to 100-fold higher
Cy5-ssODN uptake (bin 4 compared to bin 1) showed a
4-fold higher targeting frequency (Figure 5B).
Cells corrected by unmodiﬁed ssODNs progress
into mitosis
Another explanation for the reduced viability of corrected
cells could be the accumulation of cells in the G2 phase of
the cell cycle, as has been reported previously (2,10,11).
Due to the low targeting frequencies in mouse ESCs, we
could not directly determine the cell cycle proﬁle of cor-
rected cells. Instead, we determined how many cells were
able to progress into mitosis after ssODN-mediated cor-
rection of the EGFP gene. If ssODN-mediated gene cor-
rection leads to activation of a G2 arrest, relatively less
EGFP-positive cells will be able to progress into mitosis.
To address this question, Msh2
 /  mEGFP ESCs were
exposed to unmodiﬁed or PTO-modiﬁed anti-sense
ssODN 1m for 24h after which nocodazole was added
for another 12h to arrest the cells in mitosis.
Subsequently, cells were stained with MPM2 antibody to
quantify the mitotic cells in the EGFP-negative and
EGFP-positive population by ﬂow cytometric analysis
(Figure 6). Upon exposure to unmodiﬁed ssODNs,
44.2% of the uncorrected EGFP-negative cells had pro-
gressed into mitosis, which was comparable to
mock-transfected (without ssODN) control cells (48.1%,
data not shown). In the EGFP-positive population the
percentage of mitotic cells was  2-fold lower (23.4%),
indicating that cell cycle progression was impaired upon
correction by unmodiﬁed ssODNs. However, after correc-
tion by PTO-modiﬁed ssODNs only 9.8% of the corrected
EGFP-positive cells had progressed into mitosis, which
may be indicative of a more pronounced G2 cell cycle
arrest. Remarkably, the EGFP-negative cells that had
been exposed to PTO-modiﬁed ssODNs also showed a
reduced number of mitotic cells (34.6%), suggesting that
exposure to PTO-modiﬁed ssODNs already interfered
with cell cycle progression.
H2AX phosphorylation after ssODN-mediated gene
targeting
Phosphorylation of histone H2AX on Ser-139 (g-H2AX)
occurs at sites ﬂanking DNA DSBs and can be used as an
indicator for the level of DNA damage within a cell
(24,25). To investigate whether the impaired cell cycle pro-
gression was due to the activation of a DNA damage
response, we have quantiﬁed the formation of g-H2AX
following ssODN exposure (Figure 7A). Msh2
 / 
mEGFP ESCs were exposed to unmodiﬁed or
PTO-modiﬁed anti-sense ssODN 1m for 24h after which
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Figure 4. Relative colony survival of EGFP-positive cells.
Colony-forming ability of EGFP-positive Msh2
 /  mEGFP ESCs
after correction by unmodiﬁed (unm), PTO-modiﬁed and
LNA-modiﬁed anti-sense ssODN 1m (1mas). Msh2
 /  ESCs carrying
a wild-type (WT) EGFP gene were used as control. The colony survival
of the corrected EGFP-positive cells was normalized to the colony
survival of uncorrected EGFP-negative cells that had been exposed to
the same ssODNs. Error bars represent the SD of two independent
experiments.
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were simultaneously measured by ﬂow cytometry. As a
control, etoposide-treated Msh2
 /  mEGFP cells display-
ing a high level of g-H2AX (64.6%) were included in the
analysis. As shown in Figure 7A, mock-transfected
control cells already displayed an increased level of
H2AX phosphorylation (8.7%), which may be due to
the transfection procedure. In contrast, non-transfected
Msh2
 /  WT EGFP cells displayed low g-H2AX levels
(0.2%), suggesting that EGFP expression itself did not
activate a DNA damage response. Exposure to unmodi-
ﬁed ssODNs did not lead to signiﬁcant changes in H2AX
phosphorylation in both the corrected EGFP-positive cells
(5.9%) and the uncorrected EGFP-negative cells (6.3%)
when compared to the mock-transfected control cells.
However, following exposure to PTO-modiﬁed ssODNs,
g-H2AX levels in the EGFP-negative and -positive cells
were 11.7 and 25.3%, respectively, indicating that
exposure to and incorporation of PTO-modiﬁed ssODNs
triggered a DNA damage response.
Unmodiﬁed ssODNs did not induce DNA damage in
ESCs
It has been reported that correction by PTO-modiﬁed
ssODNs resulted in an increased level of genomic DSBs
(11,13,14). We have performed the neutral comet assay to
determine whether exposure to or incorporation of un-
modiﬁed ssODNs induced DSB formation. Msh2
 / 
mEGFP ESCs were exposed to unmodiﬁed or PTO-
modiﬁed anti-sense ssODN 1m for 24h. Subsequently,
the EGFP-positive and -negative cells were separated by
ﬂow cytometry and subjected to the neutral comet assay
(18). The amount of DNA damage was quantiﬁed by the
TM, which represents the product of the tail length and
the percentage of DNA in the comet tail (Figure 7B).
After exposure to unmodiﬁed anti-sense ssODN 1m,
there was no signiﬁcant difference in the median TM
value of the corrected EGFP-positive cells and the uncor-
rected EGFP-negative cells (8.4 versus 11.4, respectively)
(Figure 7C). Moreover, mock-transfected Msh2
 / 
mEGFP cells and Msh2
 /  WT EGFP control cells
showed comparable TM values (9.4 and 10.6, respective-
ly), indicating that exposure to or incorporation of un-
modiﬁed anti-sense ssODN 1m had not induced a
substantial amount of DNA damage. In contrast, the
EGFP-positive cells that were corrected by
PTO-modiﬁed anti-sense ssODN 1m showed high levels
of DSBs (median TM=39.4). A similarly high level of
DSBs was found in control Msh2
 /  mEGFP cells that
had been exposed to 25Gy of g-irradiation (median
TM=39.2). After exposure to PTO-modiﬁed ssODNs,
even the uncorrected EGFP-negative cells showed
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Figure 5. Effect of the level of ssODN uptake on colony survival and
targeting frequency. Msh2
 /  neo ESCs were transfected with
Cy5-labelled sense ssODN 4N and sorted into four equal bins based
on their Cy5 ﬂuorescence signal 24h after ssODN transfection (bin 1,
25% of cells with the lowest Cy5-ssODN uptake; bin 4, 25% of cells
with the highest Cy5-ssODN uptake). Msh2
 /  neo ESCs transfected
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binned, were included as controls (ctr). (A) Colony survival of cells that
were binned by their Cy5-ssODN uptake. (B) Targeting frequency of
cells that were binned by their Cy5-ssODN uptake. Targeting frequency
is the number of G418-resistant colonies per 10
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after sorting. Note that the calculated targeting frequencies after sorting
are lower due to the reduced survival of the plated cells. Error bars
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Figure 6. Mitotic entry following correction by ssODNs. Msh2
 / 
mEGFP ESCs were transfected with unmodiﬁed or PTO-modiﬁed
anti-sense ssODN 1m (1mas). After 24h, cells were treated with
nocodazole for 12h, ﬁxed and stained with anti-MPM2 antibody.
MPM2-positive (mitotic) cells were quantiﬁed by ﬂow cytometry in
the EGFP-positive (pos) and EGFP-negative (neg) populations. Error
bars represent SD of two independent experiments.
Nucleic Acids Research, 2010,Vol.38, No. 20 6963elevated TM values (median TM=25.0), suggesting that
both exposure to and incorporation of PTO-modiﬁed
ssODNs led to DNA damage, which is in agreement
with the g-H2AX data (Figure 7A).
In summary, we have shown that correction by unmodi-
ﬁed ssODNs did not induce a substantial amount of DNA
damage and only marginally reduced the viability of
mouse ESCs, in sharp contrast to correction by PTO-
modiﬁed ssODNs. Our results are most compatible with
physical incorporation of the ssODN into the genome,
most likely during DNA replication. Therefore, the
decline of EGFP-positive cells corrected by unmodiﬁed
anti-sense ssODNs was largely the consequence of
semi-conservative replication rather than deleterious
effects of ssODN exposure or incorporation.
DISCUSSION
In the present study, we have generated a novel Msh2-
deﬁcient mouse ESC line that carries a single copy inte-
gration of a mutant EGFP reporter gene at exactly the
same position in the Rosa26 locus as the mutant neo
reporter gene we previously described (16). This EGFP
reporter cell line enabled us to monitor gene correction
events shortly after exposure of cells to ssODNs and im-
portantly, to compare the fate of cells corrected by either
sense or anti-sense ssODNs. We demonstrate that (i)
ssODNs physically incorporated into the genome during
DNA replication; (ii) PTO-modiﬁed ssODNs were dele-
terious to cells, while unmodiﬁed ssODNs only mildly
affected cell viability; and (iii) unmodiﬁed ssODNs did
not induce DNA damage.
Superiority of anti-sense ssODNs over sense ssODNs
is a consequence of early readout
Using the neo reporter cell line, we have shown that the
targeting frequency of sense ssODN 1m was
7.0±2.8 10
 5, while the targeting frequency of
anti-sense ssODN 1m was 3.7±3.0 10
 5 (16). Here,
using the novel mEGFP reporter ESC line, similar target-
ing frequencies were obtained when the number of
EGFP-positive cells was determined 8 days after ssODN
exposure (Figures 2A and 3), indicating that both reporter
systems provided an accurate readout of the targeting fre-
quency. Strikingly, by comparing the fate of cells cor-
rected by either sense or anti-sense ssODNs, we noticed
that the recovery of gene correction events was strongly
inﬂuenced by the time of readout: initially anti-sense
ssODNs performed best, while later sense ssODNs were
most effective. We postulate that the initial strand bias
indicates that ssODNs become incorporated into the
genome: by incorporating into the transcribed strand
and replacing the original genetic information, anti-sense
ssODNs allow immediate detection of the corrected EGFP
gene. In contrast, incorporation of the sense ssODNs into
the non-transcribed strand requires the genetic alteration
to be transferred to the transcribed strand before EGFP
can be expressed (Figure 8B). Since the delay in EGFP
expression was  1day (Figure 3A), it is most likely that
this process occurred during DNA replication (Figure 8A,
model II). As we have hypothesized before (16), the
ultimate superiority of sense ssODNs over anti-sense
ssODNs may be the result of the differential accessibility
of the leading and lagging strand during replication. In
our reporter system, it seems likely that sense ssODNs
incorporated into the lagging strand.
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Figure 7. Quantiﬁcation of DNA damage after ssODN-mediated gene
targeting. (A) Quantiﬁcation of H2AX phosphorylation. Msh2
 / 
mEGFP ESCs were transfected with unmodiﬁed (unm) and
PTO-modiﬁed (PTO) anti-sense ssODN 1m. After 24h, cells were
ﬁxed and stained with anti-g-H2AX antibody. H2AX phosphorylation
was quantiﬁed by ﬂow cytometry in the corrected EGFP-positive and
uncorrected EGFP-negative cells. Mock-transfected Msh2
 /  mEGFP
cells (without ssODN), Msh2
 /  WT EGFP cells, and etoposide-treated
Msh2
 /  mEGFP cells were included as controls. Error bars represent
the SD of three independent experiments. (B) Representative
images from the neutral comet assay performed on ssODN-transfected
Msh2
 /  mEGFP ESCs with various levels of DNA damage as
quantiﬁed by the tail moment (TM; % DNA in tail   tail length).
(C) Box plot representing the distribution of the comet tail moments
after exposure to unmodiﬁed (unm) and PTO-modiﬁed anti-sense
ssODN 1m. Corrected EGFP-positive and uncorrected EGFP-
negative cells were separated by ﬂow cytometry 24h after ssODN
exposure and the level of DNA damage was quantiﬁed using the
neutral comet assay. Mock-transfected Msh2
 /  mEGFP cells
(without ssODN), Msh2
 /  WT EGFP cells and Msh2
 /  mEGFP
cells exposed to 25Gy of g-irradiation were included as controls.
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of the ssODN in ESCs during replication, in other cell
types ssODN-mediated gene targeting may occur via
replication-independent mechanisms. Using murine
myoblasts, Bertoni et al. (20) demonstrated that after cor-
rection by methyl-CpG-modiﬁed anti-sense ssODNs, the
appearance of EGFP-positive cells was delayed for 1day.
This suggests that in their system anti-sense ssODNs cor-
rected the non-transcribed strand by a repair-dependent
mechanism as shown in Figure 8A, model I.
Unmodiﬁed ssODNs only mildly reduced the viability of
corrected cells and did not induce DNA damage
The addition of PTO linkages enhanced the targeting fre-
quency of particularly anti-sense ssODNs at 24h after
transfection (Figure 2), probably by protecting the
ssODNs against nucleolytic degradation. However, after
8 days, PTO-modiﬁed anti-sense ssODNs showed the
most dramatic decrease in targeting frequency. We have
demonstrated that cells corrected by PTO-modiﬁed
ssODNs displayed a strongly reduced colony-forming
ability, an impaired cell cycle progression and activation
of a DNA damage response, which appeared to be conse-
quences of an increased level of unrepaired genomic
DSBs, as has been reported previously (11,13).
Strikingly, our results imply that the observed DNA
damage response was speciﬁc for gene correction by
PTO-modiﬁed ssODNs and did not occur when unmodi-
ﬁed ssODNs were used. First, the survival of cells cor-
rected by unmodiﬁed ssODNs was only mildly affected
when compared to cells expressing a WT EGFP gene
(Figure 4). Second, the level of uptake of unmodiﬁed
ssODNs did not affect the cell viability (Figure 5A).
Third, EGFP-positive cells corrected by unmodiﬁed
ssODNs showed similar low levels of DSBs as uncorrected
EGFP-negative cells, as determined by the g-H2AX
response and the neutral comet assay (Figure 7).
In conclusion, we have developed a unique set of
reporter cell lines carrying a single copy of either a
mutant neo or a mutant EGFP gene at the same chromo-
somal position to study the short- and long-term effects of
ssODN-mediated gene targeting. Using these cell lines, we
could demonstrate that the strand bias in favour of
anti-sense ssODNs was a consequence of early readout.
Thus, reporter systems based on EGFP expression allow
rapid recovery of gene correction events, but may be prone
to misinterpretation. We provide strong evidence that
ssODNs are incorporated during DNA replication.
Importantly, we have shown that unmodiﬁed ssODNs
do not induce a substantial amount of genomic DSBs.
Our data imply that the apparent loss of targeted cells
obtained by anti-sense ssODNs was merely the
consequence of semi-conservative replication and is there-
fore inherent to the targeting procedure. The use of un-
modiﬁed ssODNs for gene targeting ensures stable
outgrowth of targeted cells while preserving genomic in-
tegrity, features that are vital for application of this tech-
nique in (embryonic) stem cells.
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